Adaptive Biotechnologies
FRANCE LAUNCH COMPASS · All indications · All regions · All facility types · All hub clusters · All institutions
Labs & Sample Pathways

Where are samples tested, by which method and under what funding model?

All indications · All regions · All facility types · All hub clusters · All institutions

Annual lab MRD tests
9,885
MM 6,940 · CLL 2,525 · Combined MM & CLL 420 (unallocated)
Technology share (by test volume)
62%
EuroFlow NGF (8/10-Color) 62% · In-House NGS 29% · EuroFlow NGF + In-House NGS 4% · Kit-Based IVD NGS 4% · ASO-qPCR 1%
Supplied turnaround (lab medians)
2–15 d
EuroFlow NGF (8/10-Color): 2–3 d · In-House NGS: 11–14 d · Kit-Based IVD NGS: 10 d · ASO-qPCR: 15 d · EuroFlow NGF + In-House NGS: 5 d
In-house vs external samples
59% / 41%
Avg external invoiced price €192 (9 invoiced routes) · Nominal tariffs €135–€432

Annual MRD tests by laboratory and technique

8 laboratories · filtered by performing-lab host institution

Laboratory records

One record per lab × indication × technique
Laboratory
Technique
24 of 24 records
Multiple MyelomaEuroFlow NGF (8/10-Color)EuroFlow MM 8-Color Standard10^-5282072%28%G065 / N350€135
Multiple MyelomaEuroFlow NGF (8/10-Color)EuroFlow MM MRD Panel (2-Tube 8-Color)10^-5278062%38%G065 / N350€135
Multiple MyelomaEuroFlow NGF (8/10-Color)EuroFlow MM MRD Panel (IFM Reference)10^-5271060%40%G065 / N350€135
Multiple MyelomaEuroFlow NGF (8/10-Color)EuroFlow MM MRD Panel10^-5268064%36%G065 / N350€135
Multiple MyelomaIn-House NGSEuroClonality-NGS / LymphoTrack IgH/IgK/IgL10^-61264048%52%N450 / N451€432
Multiple MyelomaEuroFlow NGF (8/10-Color)EuroFlow MM 8-Color Panel10^-5262068%32%G065€135
Multiple MyelomaEuroFlow NGF (8/10-Color)EuroFlow MM MRD Panel10^-5252065%35%G065 / N350€135
Multiple MyelomaIn-House NGSEuroClonality-NGS IgH/K/L10^-61149055%45%N450 / N451€432
Chronic Lymphocytic LeukaemiaEuroFlow NGF (8/10-Color)ERIC / FILO 8-Color Flow Panel10^-5246066%34%G065€135
Combined MM & CLL (unallocated)EuroFlow NGF + In-House NGS8-Color Flow + LymphoTrack NGS10^-554200%100%RIHN / Subcontract Invoice€290
Multiple MyelomaIn-House NGSEuroClonality-NGS / LymphoTrack10^-61241052%48%N450€432
Chronic Lymphocytic LeukaemiaEuroFlow NGF (8/10-Color)ERIC / FILO CLL Flow Panel10^-5235068%32%G065€135
Multiple MyelomaIn-House NGSLymphoTrack / EuroClonality NGS10^-61334055%45%N450€432
Chronic Lymphocytic LeukaemiaEuroFlow NGF (8/10-Color)ERIC / FILO CLL 8-Color Panel10^-5234066%34%G065€135
Chronic Lymphocytic LeukaemiaEuroFlow NGF (8/10-Color)ERIC / EuroFlow CLL 8-Color Panel10^-5231070%30%G065 / N350€135
Chronic Lymphocytic LeukaemiaIn-House NGSEuroClonality-NGS IgHV Leader/FR110^-61229052%48%N450€432
Multiple MyelomaIn-House NGSLymphoTrack IgH/IgK NextSeq10^-61229074%26%N450€432
Chronic Lymphocytic LeukaemiaEuroFlow NGF (8/10-Color)ERIC / FILO CLL Flow Panel10^-5228065%35%G065€135
Multiple MyelomaIn-House NGSLymphoTrack IgH/IgK MiSeq/NextSeq10^-5 to 10^-61424058%42%N450€432
Chronic Lymphocytic LeukaemiaEuroFlow NGF (8/10-Color)ERIC / EuroFlow CLL Panel10^-5322068%32%G065€135
Multiple MyelomaKit-Based IVD NGSAdaptive clonoSEQ Assay10^-61021050%50%N450 (Trial/Sponsor)€432
Multiple MyelomaKit-Based IVD NGSAdaptive clonoSEQ Assay (IVD Kit)10^-61019040%60%N450 (Trial/Sponsor)€432
Chronic Lymphocytic LeukaemiaIn-House NGSEuroClonality-NGS IgH10^-61318054%46%N450€432
Chronic Lymphocytic LeukaemiaASO-qPCRPatient-Specific Allele-Specific IgH qPCR10^-4 to 10^-5159560%40%N350€216